PFF In The Media

The pulmonary fibrosis treatment landscape: An interview with an expert

In 2014, FDA approved two medications for idiopathic pulmonary fibrosis (IPF) — nintedanib from Boehringer Ingelheim and pirfenidone from Roche (OTCMKTS:RHHBY).

Link to Article

PFF Patients Advocate and Inspire for National Patient Recognition Week

Sharing patient stories can help spread awareness for little-known diseases like pulmonary fibrosis, empowering patients to build support systems, pinpoint symptoms and take action early.

Link to Article

Resolve to talk to your doctor in the New Year

The New Year is the perfect time to advocate for your health and commit to listening to your body for any new symptoms or warning signs.

Link to Article

There’s No Place Like Home for the COVID Holidays

It’s hard to believe, but the holiday season is upon us. In any other year, we’d be readying holiday plans for parties and get-togethers with family and friends, but this year is different.

Link to Article

What You Should Know About Pulmonary Fibrosis

Have you heard of pulmonary fibrosis? If you answered no, you are not alone.

Link to Article

Know these Pulmonary Fibrosis Risk Factors

October is Healthy Lung Month, an apt time to educate the public about the importance of protecting our lungs against mold, airborne pollutants and smoking – which put hundreds of thousands of Americans at higher risk for pulmonary fibrosis (PF).

Link to Article

Clinical Challenges: Diagnosing Idiopathic Lung Fibrosis

Approval of two antifibrotic drugs for idiopathic pulmonary fibrosis (IPF) -- pirfenidone (Esbriet) and nintedanib (Ofev) -- represented a paradigm shift in the management of the progressive fibrotic disease and potentially other interstitial lung diseases, ushering in the era of therapies that can slow lung scarring progression.

Link to Article

Dr. Sonye Danoff, Facts About Pulmonary Fibrosis

September is National Pulmonary Fibrosis Awareness Month and more than 200,000 Americans are living with pulmonary fibrosis, a lung disease with no known cure.

Link to Article

My Journey with Pulmonary Fibrosis

Texan, triathlete, wife, mother and survivor – those are just a few words I use to describe and define myself. Some would add “pulmonary fibrosis (PF) patient” to that list, but I’ve chosen not to let my diagnosis and life with PF define me.

Link to Article

Pulmonary Fibrosis: The Unsuspected Disease Affecting Over 200K Americans

While many people have heard of chronic lung diseases like COPD, asthma and cystic fibrosis, few are familiar with the interstitial lung diseases, also called pulmonary fibrosis (PF).

Link to Article

Pulmonary Fibrosis Awareness Month Shines a Spotlight on Largely Unsuspected Lung Disease

Dry cough. Fatigue. Shortness of breath. Amidst a pandemic, these symptoms appear as tell-tale signs of COVID-19.

Link to Article

Episode 133: Tom Frey

Tom Frey: A hero. The New York Police Detective began his 9/11 shift like any other day. Due to inhaling dust and debris at Ground Zero, he acquired cancer and, eventually, Pulmonary Fibrosis.

Link to Article

Driving research and awareness of pulmonary fibrosis: Pulmonary Fibrosis Foundation is leading the path to a cure

Each September, more than 200,000 Americans living with pulmonary fibrosis (PF) unite in elevating the disease profile during Pulmonary Fibrosis Awareness Month.

Link to Article

What is Pulmonary Fibrosis?

September is Pulmonary Fibrosis Awareness Month (PFAM), the perfect time to increase understanding of pulmonary fibrosis (PF), including symptoms, risk factors and treatments.

Link to Article

Guidance for Using High-Resolution CT for Interstitial Lung Disease

The Pulmonary Fibrosis Foundation (PFF) has issued a position statement that serves as a guide for conducting high-resolution computed tomography (HRCT) of the thorax for interstitial lung disease (ILD).

Link to Article

Inverness Resident Calling Attention To Life-Threatening Disease

Inverness resident Fredrick Schick, an experienced swimmer, is serving as an ambassador for a national organization in an effort to call attention to a life-threatening disease.

Link to Article

Effect of COVID-19 on Pulmonary Fibrosis Clinical Trials: Expert Interview

For patients with chronic diseases such as pulmonary fibrosis, coronavirus disease 2019 (COVID-19) represents a threat beyond the immediate risk of infection.

Link to Article

Why Pulmonary Fibrosis Is Underdiagnosed

Results of the annual Pulmonary Fibrosis Foundation (PFF) National Awareness Survey this year showed a quarter of 2000 US adults have never even heard of the disease.

Link to Article